Bionovo, Inc. (NASDAQ: BNVI) 26.3% HIGHER; announced today the publication of results from its study on the anti-tumor mechanism of BN107.
The results of the study, published in the International Journal of Cancer, describe the potential molecular mechanisms mediating the selective pro-apoptotic (cell death) effect induced by BN107 on estrogen receptor negative breast cancer cells. Click here to see the results.
AspenBio Pharma, Inc.
estrogen receptor negative breast cancerMorning Movers 12/29: BNVI, APPY, IPSU, FCEL, HOLL Higher; MACC,...StreetInsider.com News Articles Tue, 12/29/2009 - 09:23
Tags:
|
